2-溴-3-甲氧基苯胺 | 112970-44-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 2-溴-3-甲氧基苯胺
• 中文别名: 3-氨基-2-溴苯甲醚
• 英文名称: 2-bromo-3-methoxyaniline
• 英文别名: 2-bromo-3-methoxyphenylamine
• CAS: 112970-44-2
• 化学式: C₇H₈BrNO
• mdl: MFCD07787450
• 分子量: 202.051
• InChiKey: TUNIZJPEKHLBPR-UHFFFAOYSA-N

物化性质

• 沸点：
  273.1±20.0 °C(Predicted)
• 密度：
  1.531±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.142
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2922299090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  应存放在室温、干燥且密封的环境中。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Bromo-3-methoxyaniline
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Bromo-3-methoxyaniline
CAS number: 112970-44-2

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H8BrNO
Molecular weight: 202.0

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-溴-3-甲氧基苯胺 在 BrettPhos Pd G3 、 caesium carbonate 作用下， 以 甲苯 为溶剂， 反应 24.0h， 生成 替拉扎明
  参考文献：
  名称：

  吩嗪5,10-二氧化物天然产物碘丁宁，粘菌素及其衍生物的全合成和抗白血病评价。

  摘要：

  吩嗪5,10-二氧化物天然产物碘和粘菌素以及由它们衍生的新化合物的新有效全合成方法只需几个步骤即可完成，其中关键步骤是1,6-二羟基吩嗪二-N-氧化。由碘丁宁制备的类似物，包括粘菌素和2-乙氧基-2-氧代乙氧基衍生物，在大气和低氧水平下完全保留了对人类癌细胞（MOLM-13白血病）的细胞毒作用。此外，碘首次首次显示出对缺氧的选择性。白血病细胞死亡诱导的构效关系表明，N-氧化物功能水平对细胞毒性至关重要。还揭示了活性仅需要两种酚官能团中的一种，从而使另一种酚官能团被修饰而没有效力的损失。

  DOI：

  10.1016/j.bmc.2017.02.058
• 作为产物：
  描述：

  N-(3-甲氧基苯基)-2,2-二甲基丙酰胺 在 盐酸 、 正丁基锂 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 正己烷 为溶剂， 反应 15.0h， 生成 2-溴-3-甲氧基苯胺
  参考文献：
  名称：

  (2,7-二取代-1,8-联苯二氧基)双(二甲基铝)作为双齿有机铝路易斯酸：双亲电活化现象的阐明和合成效用

  摘要：

  通过用 Me3Al 处理必需的 2,7-二取代-1,8-联苯二醇 (1)，可以很容易地原位制备一系列 (2,7-二取代-1,8-联苯二氧基) 双(二甲基铝) (2) （2 当量）在室温下的 CH2Cl2 中；这主要依赖于从廉价的间茴香胺开始成功建立 1 的新合成程序。与传统的单齿路易斯酸二甲基铝 2,6-二甲苯氧化物 (11) 相比，通过使用 Bu3SnH 作为氢化物源还原酮底物，对 2 作为双齿有机铝路易斯酸进行了评估，揭示了 2 的显着高活化能力向羰基。特别是，（2,7-二甲基-1,8-联苯二氧基）双（二甲基铝）（2a）发挥了最高的反应性，这在向山羟醛反应中也得到了强调。双齿路易斯酸 2 的结构通过对具有大体积 3,5-二叔丁基苯基取代基的 2g 的单晶 X 射线衍射分析明确确定，揭示了固态的刚性二聚体组装。2a 对羰基底物的双亲电活化得到了低温 13C NMR 分析以及使用 Gaussian

  DOI：

  10.1021/ja030552s

文献信息

• Synthesis of Phenanthridines through Palladium-Catalyzed Cascade Reaction of 2-Halo-<i>N</i>-Ms-arylamines with Benzyl Halides/Sulfonates
  作者：Si-Yi Yang、Wen-Yong Han、Ding-Lei Zhang、Xiao-Jian Zhou、Mei Bai、Bao-Dong Cui、Nan-Wei Wan、Wei-Cheng Yuan、Yong-Zheng Chen

  DOI：10.1002/ejoc.201601608

  日期：2017.2.3

  An efficient palladium-catalyzed nucleophilic substitution/C–H activation/aromatization cascade reaction between readily available 2-halo-N-Ms-arylamines (Ms = methanesulfonyl) and benzyl halides/sulfonates has been described. A wide variety of phenanthridines were synthesized in a one-pot fashion in moderate to high yields (37–86 %). Notably, this method provides a straightforward, facile approach

  已经描述了容易获得的 2-卤代-N-Ms-芳基胺（Ms = 甲磺酰基）和苄基卤化物/磺酸盐之间的有效钯催化亲核取代/C-H 活化/芳构化级联反应。以一锅法以中等至高产率 (37–86%) 合成了多种菲啶。值得注意的是，该方法为菲啶的合成提供了一种直接、简便的方法。通过成功进行克级制备进一步证实了实用性。
• Novel Bicyclic Pyridinones
  申请人：Pettersson Martin Youngjin

  公开号：US20120252758A1

  公开（公告）日：2012-10-04

  Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I as defined herein. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

  所述化合物及其药用可接受的盐被披露，其中所述化合物具有如本文所定义的Formula I的结构。相应的药物组合物、治疗方法、合成方法和中间体也被披露。
• [EN] BENZOTHIADIAZINE COMPOUNDS<br/>[FR] COMPOSÉS BENZOTHIADIAZINE
  申请人：GLAXOSMITHKLINE IP DEV LTD

  公开号：WO2017098421A1

  公开（公告）日：2017-06-15

  The invention is directed to substituted benzothiadiazine derivatives. Specifically, the invention is directed to compounds according to Formula (I):wherein R, R1, R2, R3, R4 and R5 are as defined herein. The compounds of the invention are inhibitors of CD73 and can be useful in the treatment of cancer, pre-cancerous syndromes and diseases associated with CD73 inhibition, such as AIDS, autoimmune diseases, infections, atherosclerosis, and ischemia-reperfusion injury. Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting CD73 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.

  本发明涉及取代苯并噻二嗪衍生物。具体而言，本发明涉及式(I)化合物：其中R、R1、R2、R3、R4和R5定义如下。本发明的化合物是CD73的抑制剂，可用于治疗癌症、前癌综合症和与CD73抑制相关的疾病，如艾滋病、自身免疫病、感染、动脉粥样硬化和缺血-再灌注损伤。因此，本发明进一步涉及包含本发明化合物的药物组合物。本发明更进一步的涉及使用本发明化合物或包含本发明化合物的药物组合物抑制CD73活性和治疗相关疾病的方法。
• [EN] BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS<br/>[FR] COMPOSÉS BICYCLIQUES SUBSTITUÉS PAR HÉTÉROARYLE
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2018013774A1

  公开（公告）日：2018-01-18

  Disclosed are compounds of Formula (I) to (VIII): (I) (II) (III) (IV) (V) (VI) (VII) (VIII); or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate or prodrug thereof, wherein R3 is a bicyclic heteroaryl group substituted with zero to 3 R3a; and R1, R2, R3a, R4, and n are defined herein. Also disclosed are methods of using such compounds as PAR4 inhibitors, and pharmaceutical compositions comprising such compounds. These compounds are useful in inhibiting or preventing platelet aggregation, and are useful for the treatment of a thromboembolic disorder or the primary prophylaxis of a thromboembolic disorder.

  公开了公式(I)至(VIII)的化合物：(I) (II) (III) (IV) (V) (VI) (VII) (VIII)；或其立体异构体、互变异构体、药物可接受的盐、溶剂化物或前药，其中R3是与0至3个R3a取代的双环杂芳基团；且R1、R2、R3a、R4和n在此定义。还公开了使用这些化合物作为PAR4抑制剂的方法，以及包含这些化合物的药物组合物。这些化合物用于抑制或预防血小板聚集，用于治疗血栓栓塞障碍或作为血栓栓塞障碍的初级预防。
• Catalytic and Enantioselective Control of the C–N Stereogenic Axis via the Pictet–Spengler Reaction
  作者：Ahreum Kim、Aram Kim、Sunjung Park、Sangji Kim、Hongil Jo、Kang Min Ok、Sang Kook Lee、Jayoung Song、Yongseok Kwon

  DOI：10.1002/anie.202100363

  日期：2021.5.25

  chiral phosphoric acid‐catalyzed atroposelective Pictet–Spengler reaction of N‐arylindoles is reported. Highly enantioenriched N‐aryl‐tetrahydro‐β‐carbolines with C−N bond axial chirality are obtained via dynamic kinetic resolution. The hydrogen bond donor introduced on the bottom aromatic ring, forming a secondary interaction with the phosphoryl oxygen, is essential to achieving high enantioselectivity

  报道了手性磷酸催化的N-芳基吲哚的 atroposelective Pictet-Spengler 反应的一个前所未有的例子。通过动态动力学拆分获得了具有CN键轴手性的高度对映体富集的N-芳基-四氢-β-咔啉。在底部芳环上引入的氢键供体与磷酰氧形成二级相互作用，对于实现高对映选择性至关重要。这种转化可以容忍多种取代基，以提供高达 98 % 的ee. 吸电子基团取代的苯甲醛的应用能够控制轴向和点立体性。这种新的独特支架的生物学评估显示出有希望的抗增殖活性，并强调了 atroposelective 合成的重要性。